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1. INTRODUCTION 
The carboxylic ionophore, monensin, has pro- 
found inhibitory effects upon secretion of macro- 
molecules by eukaryotic cells [l-6]. In certain in- 
stances monensin has also been shown to alter post- 
translational events such as correct glycosylation 
of proteins [7,8] and the sulfation of proteoglycans 
[9,10]. When monensin impairs the secretion of 
proteoglycans from chick embryo chondrocytes 
[l 11, the bulk of the accumulated intracellular ma- 
terial is an undersulfated, underglycosylated core 
protein [12]. If a P-D-xyloside acceptor is used to 
initiate glycosaminoglycan synthesis in the pres- 
ence of monensin, undersulfated carbohydrate 
chains appear in the culture medium [ 131. Here, we 
sought to determine whether the secretion of 
xyloside-initiated chains is also impaired by 
monensin, similar to the effect upon proteoglycan 
molecules. The results indicate that even the xylo- 
side-initiated glycosaminoglycans accumulate in- 
tracellularly when monensin is present in the cul- 
ture medium. 
embryos and chondrocytes were prepared as in 
[13]. Monensin was added at 10m6 M and 4-methyl 
umbelliferyl-P-D-xylopyranoside was dissolved in 
dimethyl sulfoxide and added to the culture medi- 
um to give 1 mM xyloside and 0.2% dimethyl sul- 
foxide as final concentrations. Preincubation was 
for 1 h at 37’C on a rotary shaker bath, after 
which the chondrocytes were harvested and resus- 
pended in fresh medium containing Na235S04 
(10 ,&i/ml) and [3H]glucosamine (10 &i/ml), or 
[ “C]glucosamine (10 &i/ml) and [3H] serine 
(50&i/ml); the previous monensin and P-D- 
xyloside concentrations were maintained. After 
gassing with air containing 5% CO*, chondrocyte 
suspensions were incubated for another 4 h until 
the experiment was terminated by chilling the cul- 
tures at 4°C and then separating the cells and medi- 
um by centrifugation. 
2. MATERIALS AND METHODS 
2.1. Chondrocyte preparation and incubation 
conditions 
The sterna were dissected from 17-day-old chick 
*To whom correspondence should be addressed 
The medium was frozen after addition of the 
protease inhibitors phenylmethylsulfonyl fluoride, 
N-ethylmaleimide, EDTA, 6-amino caproic acid 
and benzamidine at final concentrations of 1, 2, 
10, 100 and 5 mM, respectively. Cell pellets were 
washed twice in phosphate-buffered saline and 
then lysed by suspension for 5 min in 1 ml 1% 
NP-40, 0.02 M Tris, 0.15 M NaCl (pH 7.4) with 
the above concentrations of protease inhibitors. 
Nuclei were pelleted by centrifugation at 15 000 
rev./min for 2 min. The supernatant was removed 
and aliquoted for direct analysis and for immuno- 
precipitation with anti-proteoglycan antiserum. 
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2.2. Immunoprecipitation of cell lysate and culture 
medium 
Immunoprecipitation was performed on samples 
labeled with [3H] serine and [ 14C] glucosamine, 
using antiserum from rabbits innoculated with 
purified PGS-1 proteoglycan which was kindly 
provided by Dr P. Goetinck (University of Con- 
necticut). Serum (20 yl) was added to 500 yl cell 
lysate or 3 ml culture medium. Incubation was at 
4°C for 15 h at which time 8 units of Calbiochem 
goat-antirabbit gammaglobulin were added. After 
2 h at 4”C, the precipitated radioactivity was pel- 
leted by centrifugation at 3000 x g for 5 min. The 
pellets were washed twice with buffer containing 
protease inhibitors, 0.5% NP-40, 0.15 NaCl, 
0.02 M Tris (pH 7.4) then resuspended in 6 M 
guanidium chloride with protease inhibitors for gel 
filtration on Sepharose 2BCL. 
2.3. Analytical procedures 
Gel filtration was performed on a Sepharose 
2BCL column (1.5 x 96 cm) or Sepharose 6BCL 
(1.5 x 97 cm) equilibrated with 4 M guanidium 
chloride, 0.05 M Tris (pH 7.0) including protease 
inhibitors. Fractions (3 ml) were collected and ana- 
lyzed for radioactive content. 
3. RESULTS AND DISCUSSION 
3.1. Gel filtration of secreted xyloside-initiated 
glycosaminoglycans 
Cultures labeled with [3H]glucosamine and 
35S04 were examined by gel filtration on Sepharose 
6BCL. The culture medium was passed through the 
gel filtration column, providing a profile of the la- 
belled macromolecules (fig. 1). A small peak is 
seen at the exclusion volume (fractions 18-21), fol- 
lowed by a major peak centered about fraction 35. 
We have shown the major peak to be xyloside- 
initiated glycosaminoglycans [ 131. The initial peak 
probably contains some residual proteoglycans 
synthesized in the presence of xyloside [14]. As 
noted in [13], the major peaks do not coincide 
exactly, for control and monensin samples, prob- 
ably as a consequence of undersulfation due to 
monensin. The 35S : 3H ratio in fig. 1, for monen- 
sin and control, were 3.3 and 4.5, respectively. The 
diminished 3H radioactivity in monensin was at 
-20% of control levels. This decrease was greater 
than reported, most likely due to the IO-fold higher 
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Fig. 1. Effects of monensin on the gel filtration profiles 
of ‘?SO4 and [3H]glucosamine-labeled glycosaminogly- 
cans initiated with a ,8-D-xyloside. The samples of cul- 
ture medium were applied to a column of Sepharose 
6BCL as in the text. Monensin was 1 PM during the 
experiments: (--) [3H]glucosamine; (----) 35S04. 
concentration of monensin used in the present 
studies. 
3.2. Gel filtration of secreted proteoglycans 
In another series of experiments, the xyloside 
was omitted but monensin was maintained at 1 ,uM. 
The proteoglycans were labeled with [ 14C]glucos- 
amine and [ 3H] serine, isolated by immunoprecipi- 
tation and passed through a Sepharose 2BCL 
column. Fig. 2 shows the elution profiles for mo- 
nensin and control samples. The peak at the void 
volume (fractions 18-20) is probably hyaluronic 
acid, which is known to co-precipitate with proteo- 
glycan and its antiserum [12,15]. The major peak, 
which is double-labeled proteoglycan [ 121, shows 
an elution differential between control and monen- 
sin samples, with the monensin peak eluting later. 
This result is consistent with our earlier demonstra- 
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Fig. 2. Effects of monensin on the gel filtration profiles 
of labeled molecules immunoprecipitated from the cultu- 
re medium with anti-proteoglycan antiserum. The preci- 
pitates were dissolved and applied to a column of Sepha- 
rose 2BCL as in the text: (-) [3H]serine; (----) 
[ r4C] glucosamine. 
tion that the pronase-derived glycosaminoglycans 
from such samples showed that the monensin ones 
eluted later than the controls [9]. The serine- 
labeled material eluting at fractions 45-48 in both 
samples is probably link protein, as indicated [ 121. 
Surprisingly, the degree of monensin-induced in- 
hibition of proteoglycan secretion is not as pro- 
nounced as seen when xyloside is used to initiate 
carbohydrate chain growth (fig. 1). 
3.3. Gel filtration of chondrocyte lysates 
The chondrocytes which had been incubated in 
the presence of xyloside were lysed and the clari- 
fied lysates were passed through the Sepharose 
6BCL column. Fig. 3 shows the elution profiles for 
these samples, which had been labeled with 13H]- 
glucosamine and 35S04. The peak appearing at the 
void region probably contains hyaluronic acid, 
some proteoglycans and other macromolecules 
such as procollagen while the peak at fractions 
35-40 is probably similar to that seen in fig. 1, 
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Fig. 3. Effects of monensin on the gel filtration profiles 
of 3S04 and [3H]glucosamine-labeled macromolecules 
obtained from chondrocytes incubated in the presence of 
a ,8-D-xyloside. Cell lysates were applied to a column of 
Sepharose 6BCL as in the text: (-) [3H]glucosamine; 
(----) 35so4. 
since it elutes at the same location and contains 
both 3H and 35S04 labels. This peak is much more 
abundant in the monensin cell lysates than in the 
control cell lysates and we believe it contains xylo- 
side-initiated glycosaminoglycans. Thus, the data 
in this figure are reciprocal to those in fig. 1 and 
suggest that the xyloside-initiated carbohydrate 
chains are accumulating in the monensin-treated 
chondrocytes. 
When xyloiside is omitted and the proteoglycans 
are immunoprecipitated from the clarified cell 
lysates, followed by their gel filtration on Sepha- 
rose 2BCL, the patterns in fig. 4 are obtained. The 
peak appearing at the void volume, analogous to 
that seen in fig. 2, is most likely hyaluronic acid 
which has co-precipitated with proteoglycan 
[ 12,151. The components eluting in fractions 30-42 
show much less correspondence between the 3H 
19 
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Fig. 4. Effects of monensin on the gel filtration profiles 
of labeled macromolecules immunoprecipitated from 
chondrocyte lysates (see text). The precipitates were dis- 
solved and applied to a column of Sepharose 2BCL as in 
the text: (-) [3H]serine; (----) [r4C]glucosamine. 
and 14C labels than seen in fig. 2, suggesting a 
more heterogeneous population of proteoglycans. 
Both labels in this region are more abundant in the 
monensin-treated samples than in the controls, 
consistent with the data of fig. 3 and with a secre- 
tory blockade due to the ionophore. The last peak 
in fig. 4, centered about fraction 45, is most likely 
to be link protein. It is also seen in fig. 2 and is 
known to co-precipitate with proteoglycan and its 
anti-serum [ 12,151. 
Monensin has multiple effects upon chondro- 
cytes, as detected by structural, biochemical and 
immunological methods. The cells show ultrastruc- 
tural changes including a distorted Golgi apparatus 
and distended rough endoplasmic reticulum [ 111. 
Both procollagen (type II) and proteoglycan accu- 
mulate in the affected cells, as shown by radio- 
immunoassay [111. The accumulated proteoglycan 
antigen contains a large proportion of undersul- 
fated and underglycosylated species [12]. The re- 
sults reported here are consistent with these earlier 
data and also demonstrate a new phenomenon, 
namely that xyloside-initiated glycosaminoglycans 
also tend to accumulate in chondrocytes when mo- 
nensin is present in the culture medium. The exact 
mechanism(s) by which monensin causes undersul- 
fation, and in the case of proteoglycans, undergly- 
cosylation, is not clear. Detailed studies of the sul- 
fation defect did not elicit any specific cause [16] 
and it may be that impaired transit of core protein 
through the chondrocyte, in conjunction with dis- 
torted Golgi structures, is sufficient to limit access 
to luminal transferases as well as to cause an in- 
crease in the proportion of underglycosylated 
species. Similar considerations may apply to the ef- 
fects of monensin upon the glycosylation of fibro- 
nectin (in human fibroblasts); a large proportion 
of the secreted fibronectin contains oligosacchari- 
des of the high mannose variety [8]. Whatever the 
specific mechanisms may be, it is clear that monen- 
sin is a most useful agent for perturbing the secre- 
tory pathway and affecting post-translational mo- 
difications of macromolecules destined for release 
from the cell. 
ACKNOWLEDGEMENTS 
This research was supported in part by NIH 
grants AM-17220 and AM-12683 to M.L.T. 
REFERENCES 
111 
PI 
131 
141 
151 
WI 
171 
PI 
[91 
Tartakoff, A. and Vassalli, P. (1977) J. Exp. Med. 
146, 1332-1345. 
Tartakoff, A. and Vassalli, P. (1978) J. Cell Biol. 
79, 694-707. 
Smilowitz, H. (1979) Mol. Pharmacol. 16, 202- 
214. 
Uchida, N., Smilowitz, H. and Tanzer, M.L. (1979) 
Proc. Natl. Acad. Sci. USA 76, 1868-1872. 
Uchida, N., Smilowitz, H., Ledger, P.W. and 
Tanzer, M.L. (1980) J. Biol. Chem. 255, 8638- 
8644. 
Ledger, P. W., Uchida, N. and Tanzer, M.L. (1980) 
J. Cell Biol. 87, 663-671. 
Tartakoff, A. and Vassalli, P. (1979) J. Cell Biol. 
83, 284-299. 
Ledger, P.W., Nishimoto, S.K., Hayashi, S. and 
Tanzer, M.L. (1982) J. Biol. Chem. in press. 
Tajiri, K., Uchida, N. and Tanzer, M.L. (1980) J. 
Biol. Chem. 255, 6036-6039. 
20 
Volume 149, number 1 FEBS LETTERS November 1982 
[lo] Mitchell, D. and Hardingham, T. (1982) Biochem. 
J. 202, 249-254. 
[l l] Nishimoto, S.K., Kajiwara, T., Ledger, P.W. and 
Tanzer, M.L. (1982) J. Biol. Chem. in press. 
[12] Nishimoto, S.K., Kajiwara, T. and Tanzer, M.L. 
(1982) J. Biol. Chem. in press. 
[13] Kajiwara, T. and Tanzer, M.L. (1981) FEBS Lett. 
134, 43-46. 
[14] Schwartz, N.B. (1977) J. Biol. Chem. 252, 
6316-6321. 
[15] Kimura, J.H., Thonar, J.M., Hascall, V.C., 
Reiner, A. and Poole, A.R. (1981) J. Biol. Chem. 
256, 7890-7897. 
[16] Kajiwara, T. and Tanzer, M.L. (1982) Arch. Bio- 
them. Biophys. 214, 51-55. 
21 
